You are here » Home » Companies » Company Overview » Coral Laboratories Ltd

Coral Laboratories Ltd.

BSE: 524506 Sector: Health care
NSE: N.A. ISIN Code: INE683E01017
BSE LIVE 12:15 | 28 Jul 1071.05 -11.95
(-1.10%)
OPEN

1062.00

HIGH

1100.00

LOW

1044.90

NSE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 1062.00
PREVIOUS CLOSE 1083.00
VOLUME 312
52-Week high 1190.00
52-Week low 448.05
P/E 23.47
Mkt Cap.(Rs cr) 382
Buy Price 1071.05
Buy Qty 19.00
Sell Price 1089.90
Sell Qty 1.00
OPEN 1062.00
CLOSE 1083.00
VOLUME 312
52-Week high 1190.00
52-Week low 448.05
P/E 23.47
Mkt Cap.(Rs cr) 382
Buy Price 1071.05
Buy Qty 19.00
Sell Price 1089.90
Sell Qty 1.00

Coral Laboratories Ltd. (CORALLABS) - Company History

Coral Laboratories Limited has been promoted by Navin B Doshi of the DWD group. The Company is spearheaded by Kishor R Mehta as Executive Director. CLL produces various pharmaceutical formulations. To Manufacture pharmaceutical formulations like tablets,capsules the company went into public issue in March 94 at a total cost of Rs.2.5 crores. The project has been completed successfully CLL plans to expand its activities in the present premises by foraying into the sophisticated FFS (form fill and seal) technology for injections. The machinery for the said technology will be imported. The Coral group is also diversifying into housing construction and financial services for which a new company, Coral India Finance and Housing, will be incorporated. During the year 1999-2000, the company has received ISO-9002 Certification.